LONGEVITY with Nathalie Niddam cover image

Episode #102: Hybrid Peptides, Peptide Research Updates, and Bioregulators

LONGEVITY with Nathalie Niddam

00:00

Yhe as Soeble, More as We Go, but Definitely, It's Worth a Try.

The next peptide we were going to talk about, which is on the agenda, was thymus and alpha one. This is a new version of thymasinapa that has very, very precise activity,. or affinity for tumer cells. Yhe as soeble, more as we go, but definitely, there's some great research around it. If you can, if you can talk your dock into writing you a prescription for it, it's definitely worth a try.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app